![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 277/62 | |
A61K 31/27 | |||
A61K 31/415 | |||
A61K 31/421 | |||
A61K 31/426 | |||
A61K 31/427 | |||
A61K 31/4439 | |||
A61K 31/505 | |||
A61K 31/506 | |||
A61P 31/18 | |||
C07C 311/29 | |||
C07C 311/41 | |||
C07C 317/40 | |||
C07C 323/49 | |||
C07D 231/12 | |||
C07D 261/08 | |||
C07D 417/12 | |||
C07D 417/14 |
(11) | Number of the document | 2632908 |
(13) | Kind of document | T |
(96) | European patent application number | 11835401.8 |
Date of filing the European patent application | 2011-10-27 | |
(97) | Date of publication of the European application | 2013-09-04 |
(45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2011/001206 |
Date | 2011-10-27 |
(87) | Number | WO 2012/055034 |
Date | 2012-05-03 |
(30) | Number | Date | Country code |
408006 P | 2010-10-29 | US |
(72) |
MORADEI, Oscar, M., CA
CRANE, Sheldon, CA
MCKAY, Daniel, J., US
LEBRUN, Marie-Eve, CA
TRUONG, Vouy Linh, CA
|
(73) |
Merck Canada Inc.,
16711 Trans-Canada Highway, Kirkland, QC H9H 3L1,
CA
|
(54) | SULFONAMIDES AS HIV PROTEASE INHIBITORS |
SULFONAMIDES AS HIV PROTEASE INHIBITORS |